S&P 500   3,102.68 (-0.03%)
DOW   27,801.42 (+0.13%)
QQQ   201.25 (-0.22%)
CGC   18.50 (-8.82%)
T   37.77 (+0.45%)
ACB   2.76 (-11.54%)
F   8.83 (+1.38%)
DIS   147.10 (+0.14%)
S&P 500   3,102.68 (-0.03%)
DOW   27,801.42 (+0.13%)
QQQ   201.25 (-0.22%)
CGC   18.50 (-8.82%)
T   37.77 (+0.45%)
ACB   2.76 (-11.54%)
F   8.83 (+1.38%)
DIS   147.10 (+0.14%)
S&P 500   3,102.68 (-0.03%)
DOW   27,801.42 (+0.13%)
QQQ   201.25 (-0.22%)
CGC   18.50 (-8.82%)
T   37.77 (+0.45%)
ACB   2.76 (-11.54%)
F   8.83 (+1.38%)
DIS   147.10 (+0.14%)
S&P 500   3,102.68 (-0.03%)
DOW   27,801.42 (+0.13%)
QQQ   201.25 (-0.22%)
CGC   18.50 (-8.82%)
T   37.77 (+0.45%)
ACB   2.76 (-11.54%)
F   8.83 (+1.38%)
DIS   147.10 (+0.14%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AnaptysBioY-mAbs TherapeuticsOdonate TherapeuticsZEALAND PHARMA/SEndo International
SymbolNASDAQ:ANABNASDAQ:YMABNASDAQ:ODTNASDAQ:ZEALNASDAQ:ENDP
Price Information
Current Price$11.82$28.33$35.79$31.67$4.67
52 Week RangeHoldBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyHold
Consensus Price Target$79.25$39.50N/A$38.33$7.42
% Upside from Price Target570.47% upside39.43% upsideN/A21.04% upside58.82% upside
Trade Information
Market Cap$299.55 million$1.13 billion$1.20 billion$1.04 billion$1.01 billion
Beta1.51.191.832.081.41
Average Volume1,764,001345,918107,1677,9247,534,998
Sales & Book Value
Annual Revenue$5 millionN/AN/A$6.02 million$2.95 billion
Price / Sales64.14N/AN/A167.400.36
CashflowN/AN/AN/A$2.93 per share$6.58 per share
Price / CashN/AN/AN/A10.800.71
Book Value$15.51 per share$2.16 per share$5.80 per share$6.60 per share($2.92) per share
Price / Book0.76N/AN/A4.80-1.60
Profitability
Net Income$-61,660,000.00$-43,270,000.00$-88,960,000.00$92.07 million$-1,031,470,000.00
EPS($2.50)($1.50)($3.64)$3.00$2.89
Trailing P/E RatioN/AN/AN/A10.561.62
Forward P/E RatioN/AN/AN/AN/A2.01
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-16.89%
Return on Equity (ROE)-20.63%-62.52%-75.22%-43.92%-99.08%
Return on Assets (ROA)-19.45%-55.17%-65.31%-36.02%5.58%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.02%N/AN/AN/A
Current Ratio14.28%7.12%8.41%5.18%1.59%
Quick Ratio14.28%7.12%8.41%4.48%1.39%
Ownership Information
Institutional Ownership PercentageN/A32.58%98.18%9.07%94.82%
Insider Ownership Percentage14.00%38.40%59.30%N/A1.50%
Miscellaneous
Employees78321171492,910
Shares Outstanding27.13 million39.73 million32.08 million31.82 million226.78 million
Next Earnings Date2/27/2020 (Estimated)3/27/2020 (Estimated)2/28/2020 (Estimated)3/5/2020 (Estimated)2/27/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 AnaptysBioY-mAbs TherapeuticsOdonate TherapeuticsZEALAND PHARMA/SEndo International

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel